Scotland's HTA Body Says Fast-Track Yes To UCB’s Bimzelx
Janssen's Ponvory To Be Funded For Relapsing-Remitting MS
The Scottish health technology appraisal body also OKd Janssen's Ponvory and new indications for AstraZeneca’s Tagrisso, Roche’s Tecentriq and MSD’s Keytruda. It also said it could not make recommendations on a number of drugs because manufacturers had not made a submission to the SMC.
